Phase II Clinical Trials in Oncology: Strengths and Limitations of Two-Stage Designs

By Schlesselman James   Reis Isildinha  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 404-412

Informa Healthcare

Access to resources Recommend Favorite

Practicalities and ethics of running clinical trials in paediatric oncology- the UK experience

By Estlin E.J.   Ablett S.  

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1394-1401

Elsevier

Access to resources Recommend Favorite

EORTC Scientific strategy meeting 25-26 March 1999 - a quality-of-life instrument for use in international clinical trials in oncology

By Meunier F.   Horiot J.-C.  

European Journal of Cancer, Vol. 35, Iss. 10, 1999-10 ,pp. : 1423-1430

Elsevier

Access to resources Recommend Favorite

Why are patients with malignant lymphomas excluded from clinical trials? The experience of an oncology institute in Italy

By Serraino D.   Zagonel V.   Bordonaro R.   Franceschi S.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 427-428

Elsevier

Access to resources Recommend Favorite

GNOSIS: Guidelines for Neuro-Oncology: Standards for Investigational Studies — reporting of surgically based therapeutic clinical trials

By Chang Susan   Vogelbaum Michael   Lang Frederick   Haines Stephen   Kunwar Sandeep   Chiocca E.   Olivi Alessandro   Quinones-Hinojosa Alfredo   Parsa Andrew   Warnick Ronald  

Journal of Neuro-Oncology, Vol. 82, Iss. 2, 2007-04 ,pp. : 211-220

Springer Publishing Company

Access to resources Recommend Favorite